Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04629820
Other study ID # MHLS 20_82
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 3, 2023
Est. completion date June 30, 2024

Study information

Verified date April 2024
Source Queen's University, Belfast
Contact Nathan G Congdon, MD, MPH
Phone 07748751393
Email ncongdon1@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will conduct a randomized-controlled trial. The participants will be textile workers aged 35 years and above with uncorrected presbyopia who are employed by a single Indian garment manufacturer - employed by Shahi Exports Private Limited, Karnataka, India - at facilities equipped to measure individual productivity. PROSPER II will assess the impact of free reading glasses on productivity for workers in a textile factory.


Description:

Globally, 3 billion people do not have the eyeglasses they need to earn, learn, travel safely in traffic and participate in civic life. Among these, 1.1 billion people lack a simple pair of reading glasses to correct impaired near vision, called presbyopia. Presbyopia, the essentially universal decline in unaided near vision that occurs with aging, is the world's most common cause of vision impairment. Loss of accommodation (ability to change focus from distance to near) due to presbyopia can begin as early as age 30 years, commonly becomes functionally apparent by 40, and is essentially complete by 55, meaning that presbyopia is most common at the height of the working years. Study Plan: This is a randomized trial designed to assess the impact of free spectacles on workplace productivity among Indian textile workers. Research question: Will providing free glasses to presbyopic Indian textile workers increase work productivity? Design: Investigator-masked, multi-center randomized controlled trial Rationale: Although presbyopia is safely, effectively and inexpensively treated with glasses, rates of optical correction in LMICs are as low as 10%. The global productivity loss due to uncorrected presbyopia has been estimated to exceed US$25 billion, and presbyopia is shown to be associated with significant impairment in activities of daily living. Few trials have been published which address the question of whether healthcare interventions can improve work performance as well as workplace retention, especially among persons over the age of 40 in low and middle-income countries (LMICs). The largest reported effect sizes among such trials was the PROSPER trial, which showed that providing inexpensive near vision glasses increased the daily weight of tea picked among presbyopic, mostly-female Indian agricultural workers by more than 5 kg (21.6%) compared to those in the control group. Costs were low, over half of pickers aged >= 40 years met criteria to receive glasses, and wearing compliance reached nearly 90%. There is interest to understand if these results from the agricultural setting can be extended to other financially-important sectors. Methods : The investigators will enrol 800 textile workers aged 35 years and above with uncorrected presbyopia who are employed by Shahi Exports Private Limited in Karnataka, India. Eligible participants will be randomly assigned to Intervention and Control Groups (1:1). Intervention group participants will receive free reading glasses within a week of undergoing a vision screening at the factory. Control group participants will receive reading glasses at the end of the assessment period (three months after vision screening). The main outcome 3 months later will be work productivity; secondary outcomes are change in skill grade, change in monthly wage, participants' adherence with spectacle wear, self-assessed self-efficacy score and change of quality of life scores. The intervention cost-effectiveness will be studied.


Recruitment information / eligibility

Status Recruiting
Enrollment 800
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 35 Years and older
Eligibility Inclusion Criteria: - Aged 35 years and older - Have presbyopia, defined as an unaided near visual acuity of N6.3 or worse in both eyes - Require a new pair of glasses to improve their near vision - Have a corrected near visual acuity of N4 or better in both eyes - Have worked in Shahi's production department as tailors or Kajbutton operators for 6 weeks or more Exclusion Criteria: - Have ocular pathology in either eye detected during the eye examination, or history of such disease based on self-report - Have a low likelihood of completing follow-up in the study due to current plans to move out of the area or leave employment at Shahi during the follow-up period

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Spectacles
Intervention group workers receive free glasses within one week of undergoing vision assessment (September 2021). The assessment period will be three months

Locations

Country Name City State
India Good Business Lab Bengaluru Karnataka

Sponsors (6)

Lead Sponsor Collaborator
Queen's University, Belfast Clearly, Good Business Lab, University of Michigan, VisionSpring, Zhongshan Ophthalmic Center, Sun Yat-sen University

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in change in mean efficiency between intervention and control group Efficiency is calculated as the proportion of target production realized by a worker per unit time Over the three month follow-up period from enrolment to study completion
Secondary Three-month change in skill grade Skill grade ranges from A triple star (highest) to A double star, A star, A, B, and C + (lowest) Between baseline and study end three months later
Secondary Change in monthly wage Monthly wage (Factory administrative data) Between baseline and study end three months later
Secondary Adherence with spectacle wear measured weekly by enumerator's unannounced observations of the presence of spectacles worn on the participant's face. Between baseline and study end three months later
Secondary Group difference in three-month change in self-assessed self-efficacy scores Self-assessed self-efficacy scores measured using the Cantril's Ladder, with the best possible score being a 10, and the worst being a 0 (Cantril's Ladder) Between baseline and conclusion of the study three months later
Secondary Group difference in three-month change of quality of life scores Quality of life scores measured using the Andhra Pradesh Eye Disease Study (APEDS) Visual Function Questionnaire (VFQ), with a 5-point Likert scale: 1=No difficulty, 2=Little difficulty, 3=Moderate difficulty, 4=Great difficulty but still can manage, 5=Cannot manage. A highest score represents great difficulty in vision function. Minimum score = 16; Maximum score = 80. Between baseline and conclusion of the study three months later
Secondary Cost effectiveness Full programme costs per individual identified and corrected with presbyopia. Programme costs include costs incurred in screening test, glasses / replacement and direct/indirect costs for facilitating work-based site. Benefit will be measured using work productivity. We will report cost effectiveness distinguishing between study costs and program costs Between baseline and study end three months later
See also
  Status Clinical Trial Phase
Completed NCT05326607 - Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia N/A
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Completed NCT05495971 - Extended Depth of Focus Contact Lenses for Presbyopia N/A
Completed NCT05464732 - Vivity IOL: Emmetropia Compared to Monovision. N/A
Recruiting NCT06045299 - Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia Phase 3
Active, not recruiting NCT04151550 - Safety & Efficacy of the Laser Scleral Microporation Procedure (Philippines) N/A
Not yet recruiting NCT05506553 - Comparison of Aspheric Toric Intraocular Lenses for Micro-monovision N/A
Completed NCT02554396 - Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia Phase 2
Completed NCT02235831 - DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance N/A
Completed NCT02214797 - Dispensing Study to Assess Visual Performance of Prototype Contact Lenses N/A
Enrolling by invitation NCT01443585 - Clinical Evaluation of a Progressive Addition Lens (PAL) N/A
Completed NCT01591499 - Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal N/A
Completed NCT04983589 - A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily Phase 3
Completed NCT02740010 - The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus
Recruiting NCT05796453 - Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix N/A
Completed NCT02516306 - A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia Phase 1/Phase 2
Completed NCT05359380 - The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living
Not yet recruiting NCT04522427 - Study of Presbyopia-correcting Intraocular Lenses in Eyes With Previous Corneal Refractive Surgery N/A
Completed NCT03688425 - Comparison of Clinical Outcomes POD L GF vs POD F GF in Asian Eyes N/A
Recruiting NCT06053463 - Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers N/A